Spruce Biosciences Price Target Boosted by 2,045.14% to $137.19
AI Summary1 min read
TL;DR
Spruce Biosciences' average price target surged 2,045.14% to $137.19, with institutional shares up 72.86% to 3,576K and portfolio weight rising 4,725.67%.
Tags
SpruceSpruce Biosciencesprice targetstock analysisinstitutional investment
Spruce Biosciences' (SPRB) average one-year price target has been revised to $137.19/share, a 2,045.14% increase from the prior estimate of $6.40/share. The price target is an average of many targets provided by analysts, ranging from $10.10 to $271.95/share. The average portfolio weight of all funds dedicated to SPRB is 0.07%, an increase of 4,725.67%. Total shares owned by institutions increased by 72.86% to 3,576K shares.
